Impel NeuroPharma is a Seattle-based company developing intranasal drug treatments for central nervous system (CNS) disorders. Impel has developed a novel drug delivery platform, the POD technology, that administers drug to the deep nasal cavity to improve the brain distribution of many drugs. Impel’s proprietary (POD) device technology enables entirely new categories of drugs, including biologics, to be delivered to the central nervous system using a cost-effective, disposable, non-invasive intranasal drug delivery device.
The goal at Impel is simple: we want to develop the next generation of therapeutics for central nervous system (CNS) disorders. Patients with CNS disorders are vastly underserved by current therapeutics and we are working hard to change that. Impel has built the POD drug delivery platform to allow entire classes of molecules to reach the brain that never could before. Impel has expanded its scope to both partnership with pharmaceutical companies and the development of our own drug products compatible with the POD platform. We take a comprehensive approach to development and design considering patient comfort, regulatory approval pathways, and cost effectiveness. Treatments currently under development include therapies for migraine, Alzheimer’s disease, Parkinson’s disease, and pain relief
|Employees (est.) (Nov 2020)||67||(-1%)|
Impel NeuroPharma total Funding
Impel NeuroPharma latest funding size
Time since last funding
|2 years ago|
Impel NeuroPharma investors
|Alliance of Angels, 5AM Ventures, Vivo Capital, KKR & Co. (Kohlberg Kravis Roberts & Co.), venBio Partners, Norwest Venture Partners|
Impel NeuroPharma has 86 Twitter Followers. The number of followers has increased 3.6% quarter over quarter
When was Impel NeuroPharma founded?
Impel NeuroPharma was founded in 2008.
Who are Impel NeuroPharma key executives?
Impel NeuroPharma's key executives are John Hoekman, Adrian Adams and Diane Wilfong.
How many employees does Impel NeuroPharma have?
Impel NeuroPharma has 67 employees.
Who are Impel NeuroPharma competitors?
Competitors of Impel NeuroPharma include Allurion Technologies, Spine Wave and Acessa (Halt Medical).
Where is Impel NeuroPharma headquarters?
Impel NeuroPharma headquarters is located at Waterfront Research Center, 201 Elliott Ave W #260, Seattle.
Where are Impel NeuroPharma offices?
Impel NeuroPharma has an office in Seattle.
How many offices does Impel NeuroPharma have?
Impel NeuroPharma has 1 office.
Receive alerts for 300+ data fields across thousands of companies